US1266501006 - Common Stock
/PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Dr. Sreekanth Chaguturu will be President, Health Care Delivery, in addition to his current role...
What's going on in today's session: S&P500 movers
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
CVS Health Corp. named Glenview Capital Management founder Larry Robbins to its board as part of an agreement with the activist firm that’s been pressuring the company for change.
/PRNewswire/ -- The Board of Directors of CVS Health (NYSE: CVS) today announced the appointment of four new board members: Leslie Norwalk, Larry Robbins, Guy...
They're down, but they aren't out, at least not in the eyes of patient investors.
Dividend-paying stocks consistently outperform those that don't pay a dividend.
Which S&P500 stocks are moving on Thursday?
Thursday's session: top gainers and losers in the S&P500 index
Curious about the S&P500 stocks that are gapping on Thursday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
CVS earnings call for the period ending September 30, 2024.
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.
US health insurers focused on the Medicare market jumped on the expectation that the second Trump administration will pay higher rates to companies that provide private versions of the US health program for seniors.
CVS Health Corp.’s new Chief Executive Officer David Joyner offered investors no guidance on the company’s expected financial performance for 2024 or 2025 in Wednesday’s earnings report, the first of his tenure.
Financial Highlights Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior year Third quarter GAAP diluted EPS of $0.07 and...
This leading REIT could be an attractive dividend play again.